Soleno Therapeutics (SLNO) Cash flow

924 Followers

Soleno Therapeutics Cash Flow

SLNO's free cash flow for Q1 2026 was $25.94M. For the 2026 fiscal year, SLNO's free cash flow was decreased by $116.04M and operating cash flow was $25.98M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ 46.80M	$ -69.10M	$ -24.94M	$ -20.78M	$ -27.77M
Investing Cash Flow	$ -201.78M	$ -225.68M	$ 0.00	$ -13.00K	$ -22.00K
Financing Cash Flow	$ 137.16M	$ 213.03M	$ 180.02M	$ 14.09M	$ -128.00K
End Cash Position	$ 70.11M	$ 87.93M	$ 169.68M	$ 14.60M	$ 21.30M
Free Cash Flow	$ 46.73M	$ -69.31M	$ -24.94M	$ -20.79M	$ -27.79M

Currency in USD